The Phase 3 ENERGIZE and ENERGIZE-T trials enrolled a total of 452 patients reflective of the real-world thalassemia population. The results demonstrated that mitapivat improves hemolytic anemia and ...
Martin, AP, Ferri Grazzi, E, Mighiu, C, Chevli, M, Shah, F, Maher, L, Shaikh, A, Sagar, A, Hubberstey, H, Franks, B, Ramos-Goñi, JM, Oppe, M and Tang, D (2022) Health state utilities for ...